Protalix BiotherapeuticsPLX
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 45 institutions reported holding Protalix Biotherapeutics Inc. (PLX) in their 13F filings, unchanged from Q3 2024. 8 opened new positions and 8 sold out. The largest holders were Renaissance Technologies ($2.1M), Northern Trust Corp. ($1.4M) and Millennium Management ($729K). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Protalix Biotherapeutics Inc.
- CUSIP
- 74365A309
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $340K |
| Exits | 8 | $273K |
All 13F filers, Q3 2024 → Q4 2024: 1,381,199 shares bought and 421,035 shares sold, net +960,164 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 45 holders
| Renaissance Technologies | 0.00% | Add +17.0% | 1,118,000 | $2.1M |
| Northern Trust Corp. | 0.00% | Add +1299.4% | 731,742 | $1.4M |
| Millennium Management | 0.00% | Add +3.8% | 387,921 | $729K |
| Gsa Capital Partners LLP | 0.04% | Reduce -29.8% | 305,749 | $575K |
| Stratos Wealth Partners, LTD. | 0.01% | No change | 270,000 | $508K |
| BlackRock, Inc. | 0.00% | Add +25.7% | 224,657 | $422K |
| Bridgeway Capital Management, LLC | 0.01% | Reduce -1.3% | 181,400 | $341K |
| Morgan Stanley | 0.00% | Add +295.3% | 170,216 | $320K |
| Citadel Advisors | 0.00% | Add +59.1% | 145,787 | $274K |
| Jane Street Group, LLC | 0.00% | Add +147.3% | 113,616 | $214K |
| Marshall Wace, LLP | 0.00% | New | 101,899 | $192K |
| Squarepoint Ops LLC | 0.00% | Add +33.4% | 73,940 | $139K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.03% | Add +13.7% | 53,507 | $101K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 50,000 | $94K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -1.1% | 49,710 | $93K |
| HSBC Holdings PLC | 0.00% | No change | 40,023 | $76K |
| Prudential Financial Inc. | 0.00% | New | 36,400 | $68K |
| Barclays PLC | 0.00% | No change | 34,323 | $65K |
| Virtu Financial LLC | 0.00% | Reduce -21.0% | 34,276 | $64K |
| Bank of America Corp. | 0.00% | Reduce -25.1% | 33,714 | $63K |
| Cubist Systematic Strategies, LLC | 0.00% | Add +24.1% | 29,307 | $55K |
| Earned Wealth Advisors, LLC | 0.02% | No change | 25,976 | $49K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -31.8% | 24,867 | $47K |
| Aptus Capital Advisors, LLC | 0.00% | Add +4.6% | 23,363 | $44K |
| PFG Investments, LLC | 0.00% | New | 20,730 | $39K |
| Y-Intercept (Hong Kong) Ltd | 0.00% | New | 18,818 | $35K |
| UBS Group AG | 0.00% | Add +6125.3% | 18,178 | $34K |
| Lido Advisors, LLC | 0.00% | No change | 15,554 | $29K |
| Kestra Advisory Services, LLC | 0.00% | Reduce -12.5% | 14,000 | $26K |
| Altshuler Shaham Ltd | 0.00% | No change | 12,142 | $23K |
| Catalyst Funds Management Pty Ltd | 0.00% | No change | 10,200 | $19K |
| Harbour Investment Management LLC | 0.01% | No change | 10,100 | $19K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 6,000 | $11K |
| Truvestments Capital LLC | 0.00% | No change | 2,458 | $5K |
| JPMorgan Chase & Co. | 0.00% | No change | 1,595 | $3K |
| Lazard Asset Management LLC | 0.00% | New | 1,255 | $2K |
| Point72 (DIFC) Ltd | 0.00% | Reduce -92.2% | 901 | $2K |
| BNP Paribas Financial Markets | 0.00% | New | 716 | $1K |
| Group One Trading LLC | 0.00% | New | 656 | $1K |
| Citigroup Inc. | 0.00% | New | 632 | $1K |
| Activest Wealth Management | 0.00% | No change | 300 | $564 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 250 | $470 |
| Y.D. More Investments Ltd | 0.00% | No change | 220 | $414 |
| Osaic Holdings, Inc. | 0.00% | No change | 200 | $376 |
| Arax Advisory Partners | 0.00% | No change | 39 | $74 |
"% of holder's portfolio" is PLX's weight in each manager's 13F, not the share of Protalix Biotherapeutics Inc. the manager owns.